COMPANY
Calidi Biotherapeutics
Timeline
- Raise Follow-on offering — Registered direct: $1.2M (total, as published), announced Sep 17, 2026. Source: SEC filing. source ↗
- Raise Follow-on offering: $6M (total, as published), announced Mar 9, 2026. Source: SEC filing. source ↗
- Raise Follow-on offering: $6.9M (total, as published), announced Aug 21, 2025. Source: SEC filing. source ↗
- Raise Follow-on offering — Registered direct: $3.9M (total, as published), announced Mar 31, 2025. Source: SEC filing. source ↗
- Raise Follow-on offering: $4.25M (total, as published), announced Jan 10, 2025. Source: company release on GlobeNewswire. source ↗
- Raise Follow-on offering: $7.5M (total, as published), announced Nov 15, 2024. Source: SEC filing. source ↗
- Raise Follow-on offering — Registered direct: $2M (total, as published), announced Oct 23, 2024. Source: SEC filing. source ↗
Funding
- Follow-on offering — Registered direct: $1.2M (total, as published), announced Sep 17, 2026. Source: SEC filing. source ↗
- Follow-on offering: $6M (total, as published), announced Mar 9, 2026. Source: SEC filing. source ↗
- Follow-on offering: $6.9M (total, as published), announced Aug 21, 2025. Source: SEC filing. source ↗
- Follow-on offering — Registered direct: $3.9M (total, as published), announced Mar 31, 2025. Source: SEC filing. source ↗
- Follow-on offering: $4.25M (total, as published), announced Jan 10, 2025. Source: company release on GlobeNewswire. source ↗
- Follow-on offering: $7.5M (total, as published), announced Nov 15, 2024. Source: SEC filing. source ↗
- Follow-on offering — Registered direct: $2M (total, as published), announced Oct 23, 2024. Source: SEC filing. source ↗